Search Results - "Tanida, N" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial

Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial

by Yamazaki, K., Yamanaka, T., Shiozawa, M., Manaka, D., Kotaka, M., Gamoh, M., Shiomi, A., Makiyama, A., Munemoto, Y., Rikiyama, T., Fukunaga, M., Ueki, T., Shitara, K., Shinkai, H., Tanida, N., Oki, E., Sunami, E., Ohtsu, A., Maehara, Y., Yoshino, T.
Published in Annals of oncology (01.01.2021)

Get full text

Journal Article

What happened to elderly people in the great Hanshin earthquake

What happened to elderly people in the great Hanshin earthquake

by Tanida, Noritoshi
Published in BMJ (02.11.1996)

Get full text

Journal Article

Doctors' and nurses' attitudes towards and experiences of voluntary euthanasia: survey of members of the Japanese Association of Palliative Medicine

Doctors' and nurses' attitudes towards and experiences of voluntary euthanasia: survey of members of the Japanese Association of Palliative Medicine

by Asai, Atsushi, Ohnishi, Motoki, Nagata, Shizuko K, Tanida, Noritoshi, Yamazaki, Yasuji
Published in Journal of medical ethics (01.10.2001)

Get full text

Journal Article

Do we always need to tell patients the truth?

Do we always need to tell patients the truth?

by Tanida, Noritoshi
Published in The Lancet (British edition) (1998)

Get full text

Journal Article

Public pretences about euthanasia in Japan

Public pretences about euthanasia in Japan

by Tanida, Noritoshi
Published in The Lancet (British edition) (19.10.1996)

Get full text

Journal Article

323P Five-year efficacy and safety in a randomized phase III trial investigating duration of adjuvant oxaliplatin-based therapy (3- vs. 6-months) for patients with high-risk stage II colon cancer: ACHIEVE-2 trial

323P Five-year efficacy and safety in a randomized phase III trial investigating duration of adjuvant oxaliplatin-based therapy (3- vs. 6-months) for patients with high-risk stage II colon cancer: ACHIEVE-2 trial

by Makiyama, A., Yamazaki, K., Shiozawa, M., Manaka, D., Kotaka, M., Sakamoto, Y., Shiomi, A., Munemoto, Y., Rikiyama, T., Fukunaga, M., Takashi, U., Shitara, K., Shinkai, H., Tanida, N., Oki, E., Misumi, T., Sunami, E., Ohtsu, A., Maehara, Y., Yoshino, T.
Published in Annals of oncology (01.09.2022)

Get full text

Journal Article

Validation of the accuracy of the H. pylori stool antigen test (HpSA) in the Japanese population

Validation of the accuracy of the H. pylori stool antigen test (HpSA) in the Japanese population

by Fukuda, Y, Tamura, K, Tomita, T, Hori, K, Tanida, N, Shimoyama, T
Published in Digestive and liver disease (2003)

Get full text

Journal Article

415P Prognostic effect of postoperative serum carcinoembryonic antigen (CEA) combined with T4 versus T3 tumors in patients with high-risk stage 2 colon cancer: ACHIEVE-2 phase III randomized clinical trial

415P Prognostic effect of postoperative serum carcinoembryonic antigen (CEA) combined with T4 versus T3 tumors in patients with high-risk stage 2 colon cancer: ACHIEVE-2 phase III randomized clinical trial

by Shiomi, A., Shiozawa, M., Manaka, D., Kotaka, M., Sakamoto, Y., Makiyama, A., Munemoto, Y., Rikiyama, T., Fukunaga, M., Ueki, T., Shitara, K., Shinkai, H., Tanida, N., Oki, E., Yamanaka, T., Sunami, E., Yamazaki, K., Ohtsu, A., Maehara, Y., Yoshino, T.
Published in Annals of oncology (01.09.2020)

Get full text

Journal Article

407P Long-term effect of peripheral sensory neuropathy (PSN) of 3 or 6 months oxaliplatin-based adjuvant chemotherapy for high-risk stage II colon cancer: ACHIEVE-2 as part of the IDEA collaboration

407P Long-term effect of peripheral sensory neuropathy (PSN) of 3 or 6 months oxaliplatin-based adjuvant chemotherapy for high-risk stage II colon cancer: ACHIEVE-2 as part of the IDEA collaboration

by Kotaka, M., Shiozawa, M., Manaka, D., Sakamoto, Y., Shiomi, A., Makiyama, A., Munemoto, Y., Rikiyama, T., Fukunaga, M., Ueki, T., Shitara, K., Shinkai, H., Tanida, N., Oki, E., Yamanaka, T., Sunami, E., Yamazaki, K., Ohtsu, A., Maehara, Y., Yoshino, T.
Published in Annals of oncology (01.09.2020)

Get full text

Journal Article

ACHIEVE-2 trial: A randomized phase III trial investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with high-risk stage II colon cancer (CC)

ACHIEVE-2 trial: A randomized phase III trial investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with high-risk stage II colon cancer (CC)

by Yoshino, T., Yamanaka, T., Shiozawa, M., Manaka, D., Kotaka, M., Gamoh, M., Shiomi, A., Makiyama, A., Munemoto, Y., Rikiyama, T., Fukunaga, M., Ueki, T., Shitara, K., Shinkai, H., Tanida, N., Yamazaki, K., Sunami, E., Ohtsu, A., Maehara, Y.
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

525O - ACHIEVE-2 trial: A randomized phase III trial investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with high-risk stage II colon cancer (CC)

525O - ACHIEVE-2 trial: A randomized phase III trial investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with high-risk stage II colon cancer (CC)

by Yoshino, T., Yamanaka, T., Shiozawa, M., Manaka, D., Kotaka, M., Gamoh, M., Shiomi, A., Makiyama, A., Munemoto, Y., Rikiyama, T., Fukunaga, M., Ueki, T., Shitara, K., Shinkai, H., Tanida, N., Yamazaki, K., Sunami, E., Ohtsu, A., Maehara, Y.
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

525OACHIEVE-2 trial: A randomized phase III trial investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with high-risk stage II colon cancer (CC)

525OACHIEVE-2 trial: A randomized phase III trial investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months) for patients (pts) with high-risk stage II colon cancer (CC)

by Yoshino, T, Yamanaka, T, Shiozawa, M, Manaka, D, Kotaka, M, Gamoh, M, Shiomi, A, Makiyama, A, Munemoto, Y, Rikiyama, T, Fukunaga, M, Ueki, T, Shitara, K, Shinkai, H, Tanida, N, Yamazaki, K, Sunami, E, Ohtsu, A, Maehara, Y
Published in Annals of oncology (01.10.2019)

Get full text

Journal Article

Do we always need to tell patients the truth?

Do we always need to tell patients the truth?

by Charlton, Rodger
Published in The Lancet (British edition) (28.11.1998)

Get full text

Journal Article

General methods for the analysis of metabolic profiles of bile acids and related compounds in feces

General methods for the analysis of metabolic profiles of bile acids and related compounds in feces

by Setchell, K D, Lawson, A M, Tanida, N, Sjövall, J
Published in Journal of lipid research (01.08.1983)

Get full text

Journal Article

Experimental gastric carcinogenesis related to Helicobacter pylori

Experimental gastric carcinogenesis related to Helicobacter pylori

by Shimoyama, T, Fukuda, Y, Sakagami, T, Yamamoto, N, Kashihara, W, Okui, M, Tanida, N, Tamura, K
Published in Hepato-gastroenterology (01.11.2001)

Get more information

Journal Article

Influence of truth disclosure on quality of life in cancer patients

Influence of truth disclosure on quality of life in cancer patients

by Tanida, N., Yamamoto, N., Sashio, H., Nakamura, Y., Sakagami, T., Sawada, Y., Shimoyama, T.
Published in International journal of clinical oncology (01.12.1998)

Get full text

Journal Article

Perceptions of Japanese patients and their family about medical treatment decisions

Perceptions of Japanese patients and their family about medical treatment decisions

by Ito, Misae, Tanida, Noritoshi, Turale, Sue
Published in Nursing & health sciences (01.09.2010)

Get full text

Journal Article

Graft-infiltrating cells in rat lung allograft with late airway damage

Graft-infiltrating cells in rat lung allograft with late airway damage

by Uyama, T, Sakiyama, S, Fukumoto, T, Tanida, N, Tamaki, M, Sumitomo, M, Monden, Y, Prop, J
Published in Transplantation proceedings (01.06.1995)

Get more information

Journal Article

Critical review on the WHO/IARC report regarding carcinogenicity of Helicobacter pylori

Critical review on the WHO/IARC report regarding carcinogenicity of Helicobacter pylori

by Tanida, N, Sakagami, T, Sawada, Y, Shimoyama, T
Published in Nihon rinshō (01.04.1997)

Get more information

Journal Article

Antibiotic therapy in eradicating Helicobacter pylori infections

Antibiotic therapy in eradicating Helicobacter pylori infections

by Shimoyama, T, Tanida, N, Fukuda, Y
Published in Nihon Naika Gakkai zasshi (10.05.1998)

Get full text

Journal Article

1
2
3
4
5
6
Next
[6]